Increased NF-κB activity in GBM has been correlated with poor prognosis and enhanced risk resistance to radiation and chemotherapy by promoting tumor initiation and progression, involving the stimulation of cell proliferation, tumor angiogenesis, and prohibition of apoptosis[58,59]. This evidence concerns the gene NFKB1 and glioblastoma.